PhytoHealth Corporation (TPE:4108)
12.80
+0.15 (1.19%)
Apr 20, 2026, 9:27 AM CST
PhytoHealth Market Cap
PhytoHealth has a market cap or net worth of 2.51 billion as of April 17, 2026. Its market cap has decreased by -20.69% in one year.
Market Cap
2.51B
Enterprise Value
1.88B
Revenue
134.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.80
Market Cap Chart
Since November 3, 2004, PhytoHealth's market cap has increased from 707.00M to 2.51B, an increase of 255.38%. That is a compound annual growth rate of 6.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.51B | -6.30% |
| Dec 31, 2025 | 2.68B | -19.64% |
| Dec 31, 2024 | 3.34B | -22.58% |
| Dec 29, 2023 | 4.31B | 13.61% |
| Dec 30, 2022 | 3.79B | -18.03% |
| Dec 30, 2021 | 4.63B | 11.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient EuroPharma | 4.11B |
| Merdury Biopharmaceutical | 3.43B |
| Maywufa Company | 2.90B |
| Allied Biotech | 2.77B |
| Johnson Chemical Pharmaceutical Works | 2.40B |
| TSH Biopharm Corporation | 1.95B |
| Tien Liang BioTech | 1.72B |
| GeneFerm Biotechnology | 1.64B |